---
figid: PMC3193409__cr2010170f4
figlink: /pmc/articles/PMC3193409/figure/fig4/
number: F4
caption: 'Expanding role of ubiquitination in protein kinase activation in diverse
  NF-κB pathways. TCR pathway (upper left): Upon TCR stimulation, the serine/threonine
  kinase PKCθ is activated by a tyrosine kinase cascade. PKCθ promotes the formation
  of a protein complex composed of CARMA1, BCL10 and MALT1. MALT1 recruits TRAF2 and
  TRAF6, which catalyze K63 polyubiquitination that leads to the activation of TAK1
  and IKK. NLR pathway (upper center): In response to bacterial peptidoglycans, cytosolic
  receptors NODs recruit TRAF proteins and target RIP2 for K63 ubiquitination, leading
  to the activation of TAK1 and IKK. RLR pathway (upper right): After viral infection,
  the viral RNA binds to the cytosolic RNA helicase RIG-I, which then binds to unanchored
  K63 polyubiquitin chains synthesized by the ubiquitin ligase TRIM25. This binding
  activates RIG-I, which transduces the signal to MAVS, a mitochondrial membrane protein.
  MAVS in turn activates IKK and TBK1, leading to the activation of NF-κB and IRF3,
  respectively. NF-κB and IRF3 enter the nucleus to induce the transcription of type-I
  interferons (IFN-Is). DNA damage pathway (bottom): Genotoxic stress caused by DNA
  double-strand breaks triggers the sequential modification of NEMO by SUMO1 and ubiquitin.
  Monoubiquitinated NEMO exits the nucleus together with ATM and this complex promotes
  K63 polyubiquitination of ELKS and/or TRAF6, which in turn activates TAK1 and IKK.'
pmcid: PMC3193409
papertitle: Expanding role of ubiquitination in NF-κB signaling.
reftext: Siqi Liu, et al. Cell Res. 2011 Jan;21(1):6-21.
pmc_ranked_result_index: '40873'
pathway_score: 0.9406111
filename: cr2010170f4.jpg
figtitle: Expanding role of ubiquitination in protein kinase activation in diverse
  NFKB pathways
year: '2011'
organisms:
- Homo sapiens
ndex: 82092834-df05-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3193409__cr2010170f4.html
  '@type': Dataset
  description: 'Expanding role of ubiquitination in protein kinase activation in diverse
    NF-κB pathways. TCR pathway (upper left): Upon TCR stimulation, the serine/threonine
    kinase PKCθ is activated by a tyrosine kinase cascade. PKCθ promotes the formation
    of a protein complex composed of CARMA1, BCL10 and MALT1. MALT1 recruits TRAF2
    and TRAF6, which catalyze K63 polyubiquitination that leads to the activation
    of TAK1 and IKK. NLR pathway (upper center): In response to bacterial peptidoglycans,
    cytosolic receptors NODs recruit TRAF proteins and target RIP2 for K63 ubiquitination,
    leading to the activation of TAK1 and IKK. RLR pathway (upper right): After viral
    infection, the viral RNA binds to the cytosolic RNA helicase RIG-I, which then
    binds to unanchored K63 polyubiquitin chains synthesized by the ubiquitin ligase
    TRIM25. This binding activates RIG-I, which transduces the signal to MAVS, a mitochondrial
    membrane protein. MAVS in turn activates IKK and TBK1, leading to the activation
    of NF-κB and IRF3, respectively. NF-κB and IRF3 enter the nucleus to induce the
    transcription of type-I interferons (IFN-Is). DNA damage pathway (bottom): Genotoxic
    stress caused by DNA double-strand breaks triggers the sequential modification
    of NEMO by SUMO1 and ubiquitin. Monoubiquitinated NEMO exits the nucleus together
    with ATM and this complex promotes K63 polyubiquitination of ELKS and/or TRAF6,
    which in turn activates TAK1 and IKK.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF3
  - TRAF3
  - TRAF6
  - KRR1
  - IKBKG
  - CD3D
  - CHUK
  - DDX58
  - BCL10
  - TAB3
  - CD3E
  - MAVS
  - TAB1
  - ATM
  - UBE2I
  - TRA
  - TAB2
  - NFKBIA
  - MALT1
  - UBE2N
  - TANK
  - NFKB1
  - TRD
  - CD247
  - TRAF2
  - CD4
  - TRIM25
  - TRG
  - TBK1
  - REL
  - TRB
  - CD3G
  - PIAS4
  - PIDD1
  - RELA
  - ERC1
  - RELB
  - NR2C2
  - NFKB2
genes:
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TRAF2/6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: RIP1
  symbol: RIP-1
  source: hgnc_alias_symbol
  hgnc_symbol: KRR1
  entrez: '11103'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3D
  entrez: '915'
- word: IKKA
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: RIG-I
  symbol: RIG-I
  source: hgnc_alias_symbol
  hgnc_symbol: DDX58
  entrez: '23586'
- word: BCL10
  symbol: BCL10
  source: hgnc_symbol
  hgnc_symbol: BCL10
  entrez: '8915'
- word: TAB2/3
  symbol: TAB3
  source: hgnc_symbol
  hgnc_symbol: TAB3
  entrez: '257397'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3E
  entrez: '916'
- word: MAVS
  symbol: MAVS
  source: hgnc_symbol
  hgnc_symbol: MAVS
  entrez: '57506'
- word: TAB1
  symbol: TAB1
  source: hgnc_symbol
  hgnc_symbol: TAB1
  entrez: '10454'
- word: ATM
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: Ubc9
  symbol: UBC9
  source: hgnc_alias_symbol
  hgnc_symbol: UBE2I
  entrez: '7329'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TAB2/3
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: IKBA
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: MALT1)
  symbol: MALT1
  source: hgnc_symbol
  hgnc_symbol: MALT1
  entrez: '10892'
- word: '{Ubc5/13'
  symbol: UBC13
  source: hgnc_alias_symbol
  hgnc_symbol: UBE2N
  entrez: '7334'
- word: TANK)
  symbol: TANK
  source: hgnc_symbol
  hgnc_symbol: TANK
  entrez: '10010'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD247
  entrez: '919'
- word: TRAF2/5N
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: CD4
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: TRIM25
  symbol: TRIM25
  source: hgnc_symbol
  hgnc_symbol: TRIM25
  entrez: '7706'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TBK1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3G
  entrez: '917'
- word: PIASY
  symbol: PIASY
  source: hgnc_alias_symbol
  hgnc_symbol: PIAS4
  entrez: '51588'
- word: PIDD
  symbol: PIDD
  source: hgnc_prev_symbol
  hgnc_symbol: PIDD1
  entrez: '55367'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: ELKS
  symbol: ELKS
  source: hgnc_alias_symbol
  hgnc_symbol: ERC1
  entrez: '23085'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: TAK1)
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
chemicals: []
diseases: []
figid_alias: PMC3193409__F4
redirect_from: /figures/PMC3193409__F4
figtype: Figure
---
